Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.61%
#2 Luxxcoin Luxxcoin +45.15%
#3 ResearchCoin ResearchCoin +21.62%
#4 Reactive Network Reactive Network +21.45%
#5 Layer3 Layer3 +19.67%
#6 Orderly Network Orderly Network +16.55%
#7 Aria.AI Aria.AI +12.61%
#8 Bitgert Bitgert +11.76%
#9 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.32%
#10 KAITO KAITO +9.04%
Coin of the day
Resolv wstUSR Resolv wstUSR
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
CSL Limited CSL Limited

CSL Limited

CSL
Classifica tra le azioni #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Prezzo delle azioni
$99.32
Capitalizzazione di mercato
$48.20B
Variazione (1 giorno)
0.98%
Variazione (1 anno)
-32.14%
Paese
AU
Scambia CSL Limited (CSL)

Categoria

Healthcare
Storico del rendimento da dividendi per CSL Limited (CSL)
Il rendimento da dividendi (TTM) di CSL Limited (simbolo azionario: CSL) al 2024-06-30 è: 1.35%
Rendimento medio negli ultimi 5 anni: 1.54%
Storico del rendimento da dividendi per CSL Limited (CSL) da 2000 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
2026 (TTM) 3.00% 59.57%
2025 1.88% 39.26%
2024 1.35% -25.41%
2023 1.81% 9.70%
2022 1.65% 66.67%
2021 0.99% 41.43%
2020 0.70% -39.13%
2019 1.15% 16.16%
2018 0.99% 2.06%
2017 0.97% -37.01%
2016 1.54% 18.46%
2015 1.30% -14.47%
2014 1.52% -7.88%
2013 1.65% -21.05%
2012 2.09% -19.62%
2011 2.60% 31.31%
2010 1.98% 47.76%
2009 1.34% 26.42%
2008 1.06% 23.26%
2007 0.86% -8.51%
2006 0.94% 28.77%
2005 0.73% 65.91%
2004 0.44% -76.84%
2003 1.90% 533.33%
2002 0.30% 15.38%
2001 0.26% -35.00%
2000 0.40% 0.00%
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.14%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
0.46%
US
UCB SA UCB SA
UCB SA
UCB.BR
0.46%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL